Cocrystal Pharma (COCP) Interest Expenses (2010 - 2026)
Cocrystal Pharma (COCP) reported Interest Expenses of -$22000.0 for Q1 2026, up 40.54% on a YoY basis from -$15653.8 in Q1 2025, and down 106.25% sequentially from $352000.0 in Q4 2025.
Cocrystal Pharma (COCP) Interest Expenses (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 17 years of Interest Expenses data on file, last reported at -$22000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 40.54% year-over-year to -$22000.0; the trailing twelve-month figure through Mar 2026 stood at -$290000.0 (up 8.52% YoY), and the FY2025 full-year result was $674000.0, down 14.58% from the prior year.
- Interest Expenses retreated to -$22000.0 in Q1 2026, from $352000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $2.1 million in Q2 2024 to a low of -$583000.0 in Q4 2024.
- A 5-year average of $197882.4 and a median of $56000.0 in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses plunged 1784.21% in 2023 and soared 1070.88% in 2024, its largest moves.
- Tracing COCP's Interest Expenses over 5 years: stood at -$152000.0 in 2022, then soared by 444.08% to $523000.0 in 2023, then sank by 211.47% to -$583000.0 in 2024, then surged by 160.38% to $352000.0 in 2025, then tumbled by 106.25% to -$22000.0 in 2026.
- Business Quant data shows COCP's Interest Expenses at -$22000.0 in Q1 2026, $352000.0 in Q4 2025, and $242000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.17 Bn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | -22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 268,000.00 |
| Jun 30, 2025 | 268,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Dec 31, 2024 | -583,000.00 |
| Dec 31, 2024 | -583,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 2.13 Mn |
| Mar 31, 2024 | -220,000.00 |
| Mar 31, 2024 | -220,000.00 |
| Dec 31, 2023 | 523,000.00 |
| Dec 31, 2023 | 523,000.00 |